211
Participants
Start Date
September 9, 2013
Primary Completion Date
August 6, 2014
Study Completion Date
September 1, 2014
JNJ 49095397
JNJ 49095397 400 microgram will be inhaled by participants once daily by using a dry powder inhaler for 12 weeks.
Placebo
Placebo will be inhaled by participants once daily by using a dry powder inhaler for 12 weeks.
Phoenix
St Louis
Chapel Hill
Charlotte
Cincinnati
Spartanburg
Antwerp
Brussels
Genk
Kortrijk
Leuven
Calgary
Edmonton
Hamilton
Ottawa
Toronto
Montreal
Sainte-Foy
Sherbrooke
Prague
Berlin
Frankfurt
Großhansdorf
Hamburg
Lübeck
Mainz
Budapest
Farkasgyepü
Mosonmagyaróvár
Szikszó
Eindhoven
Groningen
Rotterdam
Sittard / Geleen
Zwolle
Bialystok
Lodz
Wroclaw
Bucharest
Barnaul
Moscow
Saint Petersburg
Bristol
Dundee
Edinburgh
Glasgow
London
Janssen Research & Development, LLC
INDUSTRY